World's 1st test using iPS cells to treat corneal disease

World's 1st test using iPS cells to treat corneal disease

Osaka University professor Koji Nishida (2nd from R) speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000152355
  • Registered date
  • 2019/3/05 19:34:11
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2019 Kyodo News
  • Media size
  • 3968 × 2754 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 806.79(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japan gov't panel approves 2 iPS-derived drugs

    Japan gov't panel approves 2 iPS-derived drugs

    University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
      Japan gov't panel approves 2 iPS-derived drugs

      Japan gov't panel approves 2 iPS-derived drugs

      University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
        Japan gov't panel approves 2 iPS-derived drugs

        Japan gov't panel approves 2 iPS-derived drugs

        University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.

          World's 1st wooden satellite

          Takao Doi, a Japanese astronaut and a program-specific professor at Kyoto University, speaks about the world's first-ever wooden satellite "LignoSat" during an interview in Kyoto, western Japan, on May 28, 2024. Scientists at Kyoto University and Tokyo-based wood products company Sumitomo Forestry Co. developed the spacecraft, a cube with 10-centimeter sides and weighing 1 kilogram.(Kyodo)
            Stockholm water Prize laureate Oki

            Stockholm water Prize laureate Oki

            Taikan Oki, professor of the School of Engineering at the University of Tokyo, speaks during a press conference in Tokyo on March 25, 2024, after winning the Stockholm Water Prize, the world's most prestigious water award given out by Stockholm Water Foundation in cooperation with the Royal Swedish Academy of Sciences.
              Reproductive genetics scientist Hayashi

              Reproductive genetics scientist Hayashi

              SUITA, Japan, July 31 Kyodo - Photo taken on Jan. 18, 2023, shows Osaka University Professor Katsuhiko Hayashi at a university campus in Suita, Osaka Prefecture. The reproductive genetics scientist's team succeeded in producing mice eggs using iPS cells. (Kyodo)
                (FOCUS)CHINA-YANGTZE RIVER DELTA-QUANTUM SCIENCE AND TECHNOLOGY-SCIENTIST-PENG CHENGZHI (CN)

                (FOCUS)CHINA-YANGTZE RIVER DELTA-QUANTUM SCIENCE AND TECHNOLOGY-SCIENTIST-PENG CHENGZHI (CN)

                (230808) -- HEFEI, Aug. 8, 2023 (Xinhua) -- Peng Chengzhi (1st R, back), Pan Jianwei (2nd R, front), Wang Jianyu (1st L, front), Yin Juan (2nd R, back) and Ren Jigang (3rd R, back) look at data received from quantum satellite "Micius" at Lijiang observatory in Lijiang city, southwest China's Yunnan Province, Dec. 22, 2016. Peng Chengzhi, born in 1976, holds several professional positions: professor and doctoral supervisor at the University of Science and Technology of China (USTC), chief scientist of QuantumCTek Co., Ltd., and chief engineer of the scientific application system of Micius, the world's first quantum communication satellite. Peng began to participate in the research of quantum science and technology in 2003. Since then, he has taken part in the whole process of the design of the quantum satellite "Micius", witnessing the development of China in the fields of quantum communication, quantum computing and others. Since the USTC and QuantumCTek Co., Ltd are based in Hefei, while the Shanghai I
                  World's 1st transplant of iPS heart muscle tissue

                  World's 1st transplant of iPS heart muscle tissue

                  Osaka University professor Yoshiki Sawa (L) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                    World's 1st transplant of iPS heart muscle tissue

                    World's 1st transplant of iPS heart muscle tissue

                    Osaka University professor Yoshiki Sawa (R) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                      World's 1st transplant of iPS heart muscle tissue

                      World's 1st transplant of iPS heart muscle tissue

                      Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo